Late Effects Screening Guidelines after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement From the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects After Pediatric HCT
Andrew C. Dietz(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Blanche P. Alter(University of North Carolina at Chapel Hill), Sharon A. Savage(National Institutes of Health), Carmem Bonfim(Universidade Federal do Paraná), Adrianna Vlachos(Feinstein Institute for Medical Research), Roderick Skinner(Royal Victoria Infirmary), K. Scott Baker(Fred Hutch Cancer Center), Jeffrey M. Lipton(Feinstein Institute for Medical Research), Jakub Tolar(University of Minnesota), Farid Boulad(Memorial Sloan Kettering Cancer Center), Dorine Bresters(Willem-Alexander Kinderziekenhuis), John E. Wagner(NHS Blood and Transplant), Parinda A. Mehta(Cincinnati Children's Hospital Medical Center), Jean Hugues Dalle(Université Paris Cité), Josu de la Fuente(Imperial College Healthcare NHS Trust), Christine Duncan(Dana-Farber Cancer Institute), Michael A. Pulsipher(Children's Hospital of Los Angeles)
Cited by 61
Related Papers
Hematotoxicity in Workers Exposed to Low Levels of Benzene
|Science|2004|623
Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy
|New England Journal of Medicine|2017|592
Hyponatremia among Runners in the Boston Marathon
|New England Journal of Medicine|2005|553